Breaking News
June 23, 2018 - Infant omega-3 supplementation tied to decreased waist size
June 23, 2018 - Massive analysis of genomes reveals insights into genetic overlap among psychiatric diseases
June 23, 2018 - New therapeutic approach may delay neurodegeneration in rare genetic disease
June 23, 2018 - Broken shuttle protein may hinder learning in patients with brain disorders
June 23, 2018 - Study finds increase in daily cannabis use among American adults
June 23, 2018 - Researchers create electronic skin that brings back real sense of touch to prosthetic limbs
June 23, 2018 - FIRS: Guidance Offered for Protecting Youth From E-Cigarettes
June 23, 2018 - Scientists unravel molecular mechanisms of Parkinson’s disease
June 23, 2018 - When the Heart Stops, Drugs Often to Blame
June 23, 2018 - Scientists show that a key Parkinson’s biomarker can be identified in the retina
June 23, 2018 - Study finds factors underlying current rise in radicalization among European youth
June 23, 2018 - New study finds higher heart disease risk in bisexual men
June 23, 2018 - Coconut oil diet increases vitality, lifespan of fruit flies with peroxisomal disorder
June 23, 2018 - Jumping genes or transposons and their role in the genetic code
June 23, 2018 - The Current issue of “The view from here” is concerned with Therapeutics
June 23, 2018 - Abnormal lipid metabolism in fat cells predicts future weight gain and diabetes in women
June 23, 2018 - Alcohol problems linked to sex without condom use among black gay men
June 23, 2018 - DNA patterns in circulating blood cells can help identify spastic cerebral palsy
June 23, 2018 - Unsubstantiated health claims widespread within weight loss industry
June 23, 2018 - FDA grants marketing authorization for use of two catheter-based devices in hemodialysis patients
June 23, 2018 - An ingrown toenail not the same as a bypass
June 23, 2018 - Study suggests proteinuria lowering as important target in managing pediatric CKD
June 23, 2018 - Schizophrenia patients account for over 1 in 10 suicide deaths, study shows
June 23, 2018 - Overdose risk increases five-fold with concurrent opioid and benzodiazepine use
June 23, 2018 - FDA Alert: Kratom (mitragyna speciosa) powder products by Gaia Ethnobotanical: Recall
June 23, 2018 - Study highlights inadequate effort of health care insurers to combat opioid epidemic
June 23, 2018 - CDC chief asks for, and gets, cut to his record $375K pay
June 22, 2018 - Novel cellular pathway may clarify how arterial inflammation develops into atherosclerosis
June 22, 2018 - Pioneering exercise program improves physical, mental health of elderly people living in care homes
June 22, 2018 - Rutgers Cancer Institute educates childhood cancer survivors about late effects of treatment
June 22, 2018 - Study tests accuracy of device designed to detect heart dysfunction in childhood cancer survivors
June 22, 2018 - Study links annual haze with increased hospitalizations for respiratory problems
June 22, 2018 - Robotic surgery appears to be as effective as open surgery in treating bladder cancer
June 22, 2018 - Many Drugs Made Available Via FDA Expanded Access Programs
June 22, 2018 - Normal eye dominance is not necessary for restoring visual acuity in amblyopia
June 22, 2018 - Parent-Child Interaction Therapy can reduce depression rates in children
June 22, 2018 - Study provides insights into how components of different cells in the brain are altered
June 22, 2018 - Research does not confirm antidiabetic action of natural fatty acid derivatives
June 22, 2018 - Oxidative stress can be used against tumors to treat cancer
June 22, 2018 - Simple, cost-effective test may help improve early diagnosis of mild cognitive impairment
June 22, 2018 - New guide published to help battle fatal disease caused by kissing bugs
June 22, 2018 - Stigma Adds to Burden of Type 1 Diabetes
June 22, 2018 - In retinoblastoma survivors, oculo-visual issues tied to QoL
June 22, 2018 - Most adults with allergies do not use prescribed epinephrine even in emergency situations
June 22, 2018 - Study provides clues to how cancer cells develop resistance to chemotherapies
June 22, 2018 - New consensus paper serves as basis for uniform medical management of DSD
June 22, 2018 - Researchers work to identify areas of the brain that help us wake up
June 22, 2018 - Alcohol hangovers more significant and costly than people realize, shows research
June 22, 2018 - Targeting cells involved in blood vessel formation could hinder brain tumor growth
June 22, 2018 - Young cancer survivors need more support as they feel dissatisfied with their sexuality
June 22, 2018 - Unusual cell-to-cell communication in glioblastoma promotes aggressiveness and therapy resistance
June 22, 2018 - Turning A Phage – Drug Discovery Today
June 22, 2018 - World-first study links birth interventions and long-term childhood illness
June 22, 2018 - Improving the quality of biomedical research samples
June 22, 2018 - Researchers identify cerebral palsy using AI and DNA sequencing
June 22, 2018 - Administering nitric oxide gas after heart surgery may decrease risk of kidney problems
June 22, 2018 - Measuring levels of ethyl sulphate in hair can help assess alcohol consumption
June 22, 2018 - Researchers develop robot bloodhound that can rapidly detect odors on the ground
June 22, 2018 - AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer
June 22, 2018 - LSTM led consortium receives grant to investigate how human behavior impacts AMR
June 22, 2018 - Researchers discover drug compound that inhibits movement of cancer cells
June 22, 2018 - Normalization of ‘plus-size’ body shapes may prevent recognition of health risks of obesity
June 22, 2018 - UC San Diego launches new bacteriophage therapy center
June 22, 2018 - New review outlines current state of sex-sensitive issues linked to heart failure drugs
June 22, 2018 - Pelvic pain a major issue for women nearing mid-life, research reveals
June 22, 2018 - Researchers develop reliable DNA barcodes for biomedical research
June 22, 2018 - New risk-prediction model may help identify diabetic patients at high risk of pancreatic cancer
June 22, 2018 - Study reveals how mTORC1-driven changes in crowding could influence major diseases
June 22, 2018 - Researchers uncover new therapeutic opportunity in the treatment of malignant melanoma
June 22, 2018 - UC Riverside researcher receives grants to advance cancer, ALS research
June 22, 2018 - Radiation therapy alone may be enough to treat older, sicker patients with anal cancers
June 22, 2018 - Technical report describes how to make accurate particle size measurements on carbon black samples
June 22, 2018 - Nocdurna (desmopressin acetate) Approved by FDA as First Sublingual Tablet to Treat Nocturia due to Nocturnal Polyuria
June 22, 2018 - Neuroscientists locate neurons in the brain that respond when a visual target is found
June 22, 2018 - First human Keystone virus infection reported
June 22, 2018 - New study reveals how ‘good’ bacteria help in regulating our metabolism
June 22, 2018 - Osteopathic manual therapy affecting the diaphragm improves chronic low back pain
June 22, 2018 - Researchers create revolutionary model to study pulmonary diseases
June 22, 2018 - Diagnosing Heart Disease Using AI
June 22, 2018 - Increasing biodefense risks posed by synthetic biology
Medical device coated with new bacteria resistant materials approved for use by hospitals

Medical device coated with new bacteria resistant materials approved for use by hospitals

image_pdfDownload PDFimage_print

A medical device coated with new bacteria resistant materials, discovered by a team at the University of Nottingham, has been approved for use by hospitals in the UK and Europe.

The specially coated urinary catheter has just been awarded a CE mark. Devices are about to be trialed in 6 hospitals across the­­ UK. The trial will help to determine whether promising laboratory results translate into significantly reduced infection rates and lower costs for patients needing a catheter.

The bacteria resistant materials discovered in 2012 by a scientists in the Schools of Pharmacy and Life Sciences, have been developed for medical use by the Cambridgeshire company Camstent. Meanwhile research, funded by Wellcome, to understand why these materials work is going into the final phase.

Morgan Alexander, Professor of Biomedical Surfaces, who led the team funded by a Wellcome Trust Translation Award that made the initial discovery said: “This has gone all the way from the discovery of a new class of materials that no one could have predicted all the way to clinical trials and that’s a massive achievement. This is only the second medical product to ever come out of this type of high throughput materials discovery that I am aware of and although the new CE mark is for urinary catheters only we have had a lot of interest from companies who manufacture other medical devices. This is an exciting time.”

Dr Dave Hampton, Chief Technical Officer, at Camstent said: “Catheter acquired urinary tract infections account for 38% of all hospital acquired infections prolonging the time patients spend in hospital and costing many of them their lives. These infections also cost the healthcare systems around the world billions in unplanned care, increased medication and congested waiting lists. The research published by the University of Nottingham presented us with a possible solution to this problem and it’s exciting to now have a product reaching clinical trial, it’s a real landmark moment for the project.”

Paul Williams, Professor of Molecular Microbiology in the Centre for Biomolecular Sciences said: “In the context of antimicrobial resistance these materials could be a major breakthrough. Millions of urinary catheters are used every day around the world and anybody who has a catheter for longer than a week is likely to get an infection.”

Medical device associated infections

Medical device associated infections can lead to systemic infections and device failure, costing the NHS over £1bn a year. Many commonly used devices including urinary and central venous catheters are susceptible biofilms that are essentially bacterial ‘slime cities’. This lifestyle protects bacteria from the bodies’ natural defenses and antibiotics.

Back in 2012 the Nottingham team discovered a new group of structurally related polymers that dramatically reduced the attachment of pathogenic bacteria (including Pseudomonas, Proteus, Staphylococcus and Escherichia coli).

These new materials prevent infection by stopping biofilm formation at the earliest possible stage — when the bacteria attempt to stick irreversibly to the device.

The discovery was made with the help of experts from the Massachusetts Institute of Technology (MIT) — who initially developed the materials micro-array process by which thousands of unique polymers could be screened simultaneously.

Discovery and development

Professor Alexander said: “We do materials discovery, Camstent have done the product development. Between the point our team discovered this material and tested it on a little tube in the lab to Camstent developing a coated device there have been a host of important optimization experiments. We needed to get the coating to the appropriate flexibility, get it to stick and then safety tested and manufactured ready for clinical trials.” The process of getting CE approval so these new materials could be tested on humans involved many well documented repetitive experiments to ensure they work and they are safe. Camstent have put them through a detailed manufacturing quality process to test the coating, packaging and sterilization process.

Dr Hampton said: “As well as rigorous safety tests the production process has to be tested to ensure it works and there are no faults in the manufacture and we have to ensure the devices remain sterile in the packaging. We are very confident that we have reached a stage where patients will benefit from using this new device as opposed to the traditional uncoated or silver impregnated ones and we are very excited to see the results of these trials and move onto the next stage of the process. “

Analysing the results

To test whether the materials are working properly the used catheters will be sent to the University of Nottingham where they will be examined for signs of biofilm formation by Professor Williams and his team.

Potential for other medical devices

Having licensed the materials for use in urology the team at Nottingham are now looking to use their materials on other medical devices. As well as catheters these include endotracheal tubes used to help unconscious patients breath and contact lenses. The coating could also be used for implants such as cochlear implants, prosthetic joints and dental products.

Still more questions to answer

With the discovery of new group of materials like these come big questions and Professor Morgan and his team still have some to answer.

Professor Alexander said: “We know how these materials work but the more complex question is why they work. If we can understand the mechanisms involved we can expand the application of these polymers, eg into implants and other devices. The Wellcome Trust Senior Joint Investigator award that Profs. Alexander and Williams have currently is helping us to discover why bacteria dislike our polymer surfaces so much.”

Dr Tim Knott of Wellcome’s Innovations team said: “Innovative approaches to tackling the spread of infection are vital to stop the rise of drug-resistant infections. Often called superbugs, they already kill 700.000 people each year worldwide. This new material could be hugely important in helping prevent spread of potentially deadly infection and in addressing an urgent global health problem. Reducing infection is vital for patients and for healthcare systems across the world. Wellcome is committed to tackling drug-resistant infections and we look forward to the clinical trial for this exciting medical innovation.”

Source:

https://www.nottingham.ac.uk/news/pressreleases/2018/april/new-bacteria-resistant-materials-get-go-ahead-for-trials-on-humans.aspx

Tagged with:

About author

Related Articles